Clinical trial
Oral Miltefosine for the Treatment of Pediatric Cutaneous Leishmaniasis in…
NCT00487253 · Centro Internacional de Entrenamiento e Investigaciones Médicas, Other · Unknown status
Key facts
| NCT number | NCT00487253 |
|---|---|
| Title | Oral Miltefosine for the Treatment of Pediatric Cutaneous Leishmaniasis in Colombia |
| Official title | Randomized Clinical Trial of the Efficacy and Tolerability of Oral Miltefosine Versus Parenteral Antimony for the Treatment of Pediatric Cutaneous Leishmaniasis in Colombia |
| Lead sponsor | Centro Internacional de Entrenamiento e Investigaciones Médicas, Other |
| Collaborators | Instituto Colombiano para el Desarrollo de la Ciencia y la Tecnología (COLCIENCIAS) INS Instituto Nacional de Dermatología Centro dermatológico Federico Lleras Acosta |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Cutaneous Leishmaniasis |
| Intervention type | Drug |
| Interventions | Miltefosine, Meglumine antimoniate |
| Enrollment | 150 |
| Start date | Jul 1, 2007 |
| Primary completion | Feb 1, 2010 |
| Completion | Dec 1, 2010 |
| First posted | Jun 18, 2007 |
| Last update posted | Feb 17, 2010 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: